Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to CalTech, Engeneic, and More

Premium

Title: Bacterially Derived Intact Minicells That Encompass Plasmid-free Functional Nucleic Acid for In Vivo Delivery to Mammalian Cells

Patent Number: 8,669,101

Filed: Dec. 29, 2010

Lead Inventor: Himanshu Brahmbhatt, Engeneic Molecular Delivery


Title: Polyion Complex of Double-stranded Ribonucleic Acid

Patent Number: 8,668,933

Filed: March 31, 2010

Lead Inventor: Yuichi Hori, University of Tokyo


Title: Biotinylated Compositions

Patent Number: 8,669,236

Filed: May 12, 2006

Lead Inventor: David Elmaleh, Children's Medical Center


Title: Modulation of Innate Immunity Receptors' Signaling by microRNAs miR-146a and miR-146b

Patent Number: 8,669,235

Filed: March 22, 2007

Lead Inventor: David Baltimore, California Institute of Technology

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.